VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VNDA

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2022/04/29	06:00	PR Newswire (US)	Vanda Pharmaceuticals to Announce First Quarter 2022 Financial Results on May 5, 2022	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/04/26	05:33	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/03/02	06:19	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/02/24	06:11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/02/24	06:01	PR Newswire (US)	Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/02/18	08:00	PR Newswire (US)	Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/02/14	20:23	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/02/04	21:08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/02/04	21:00	PR Newswire (US)	Vanda Pharmaceuticals Reports Results from the Phase III Study of Tradipitant in Gastroparesis	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/01/28	07:18	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/01/26	23:20	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/01/15	06:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2022/01/14	22:35	PR Newswire (US)	Vanda Pharmaceuticals Settles HETLIOZ® Patent Litigation with MSN	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/12/03	06:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/11/11	08:30	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation at November 2021 Investor Conferences	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/11/04	05:01	PR Newswire (US)	Vanda Pharmaceuticals Reports Third Quarter 2021 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/10/28	06:30	PR Newswire (US)	Vanda Pharmaceuticals to Announce Third Quarter 2021 Financial Results on November 3, 2021	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/10/15	05:30	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation at Evercore ISI's Catalyst Day	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/10/09	05:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/09/17	21:53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/09/08	09:30	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation at the Citi 16th Annual BioPharma Virtual Conference	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/08/24	05:36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/08/18	05:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/08/03	20:00	PR Newswire (US)	Vanda Pharmaceuticals Closes Enrollment In The ODYSSEY Study Comparing Tradipitant And Placebo In Hospitalized COVID-19 Pneumonia Patients	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/07/30	22:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/07/29	05:01	PR Newswire (US)	Vanda Pharmaceuticals Reports Second Quarter 2021 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/07/28	05:37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/07/22	05:30	PR Newswire (US)	Vanda Pharmaceuticals to Announce Second Quarter 2021 Financial Results on July 28, 2021	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/06/18	06:02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2021/06/16	05:43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc